![]() |
市场调查报告书
商品编码
1953432
生物防治市场-全球产业规模、份额、趋势、机会及预测(依产品类型、功能、处理方法、作物类型、地区和竞争格局划分,2021-2031年)Biocontrol Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Function, By Mode of Treatment, By Crop Type, By Region & Competition, 2021-2031F |
||||||
全球生物防治市场预计将从 2025 年的 42.1 亿美元成长到 2031 年的 67.8 亿美元,复合年增长率为 8.26%。
该领域专注于利用微生物、大型生物和讯息化合物等天然生物体和物质来防治农业害虫和植物病害。推动这一领域发展的关键因素包括政府加强监管以限制合成化学品的使用,以及全球消费者对无化学残留食品日益增长的偏好。此外,由于害虫已对传统杀虫剂产生抗药性,因此迫切需要强有力的抗药性管理策略来应对,这也积极推动了生物药品的应用。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 42.1亿美元 |
| 市场规模:2031年 | 67.8亿美元 |
| 复合年增长率:2026-2031年 | 8.26% |
| 成长最快的细分市场 | 宏观生物学 |
| 最大的市场 | 北美洲 |
儘管呈现上升趋势,但该行业仍面临许多挑战。根据国际生物防治製造商协会的数据,欧洲生物防治市场预计到2024年将达到16亿欧元,年增长率接近10%,但复杂且分散的监管环境阻碍了其更广泛的扩张。各地区冗长且不一致的核准程序常常延缓商业性产品的上市,限制了製造商快速将新产品推向市场以满足农业需求的能力。
主要作物保护产品生产商的策略性资本配置和产品系列多元化是市场成长的关键驱动因素。面对日益严格的合成农药监管和市场不稳定,产业领导者正积极转向生物产品线,以确保稳定的收入来源。这种策略调整正在产生切实的商业效益。例如,科迪华农业科技公司在2025年2月发布的「2024年第四季财务业绩」报告中指出,其作物保护剂销售量年增16%,这主要归功于拉丁美洲对生物农药和新型产品的强劲需求。此类企业措施有助于先进配方的快速商业化,有效地将专业研究与大众市场应用联繫起来。
综合虫害管理(IPM)策略的广泛应用进一步推动了这一成长。随着种植者寻求永续的抗药性管理方法,他们越来越多地将生物製剂与传统处理方法结合使用,这一转变正在改变分销策略。根据CropLife于2025年3月发布的《生物农药调查》,86%的受访农资零售商计划在即将到来的种植季扩大其生物农药产品的类型。这种激增的需求正在主要农业地区创造巨大的市场价值。正如《Revista Cultivar》杂誌在2025年11月报道的那样,2024/25作物年度巴西生物农药的销售额达到43.5亿雷亚尔,比上一年增长18%。
监管环境的碎片化和复杂性仍然是全球生物防治市场成长的一大障碍。与合成农药不同,生物製品在许多地区缺乏特定的註册途径,迫使生产者遵循繁琐的化学品审批通讯协定。这种不一致导致数据要求过高,合规成本也随之增加,给作为行业关键创新者的中小企业带来了沉重负担。因此,核准流程带来的经济负担和不确定性抑制了对新产品研发的投资,并延缓了永续害虫防治解决方案的上市。
监管效率低下的影响在比较不同区域市场时特别显着。根据国际生物防治产品製造商协会(IBMA)2024年的报告,欧洲农民获得生物防治产品核准的等待时间长达10年,而美国和巴西的竞争对手通常只需两到三年即可进入市场。这种显着的差距限制了核准流程缓慢地区有效生物防治产品的供应,从而限制了整体市场潜力,并阻碍了该行业满足全球对零残留农业投入品迫切需求的能力。
基于RNA干扰(RNAi)技术的生物农药的兴起,标誌着精准、非基因害虫防治方案的重大转变,有效应对了日益严重的化学抗药性问题。与传统的频谱农药不同,这些喷洒型製剂利用双链RNA惰性。这不会改变植物基因组,也不会伤害益虫,从而避免了基改作物(GMO)所面临的监管和公众接受度方面的挑战。该领域的商业化进程正在加速,生产商正将产品从田间试验推进到大规模分销。例如,Greenlight Biosciences公司于2025年3月宣布,已获得2500万美元的资金筹措,用于进一步商业化其首款註册的叶面喷布RNA生物农药Karantha,该产品专为防治科罗拉多马铃薯甲虫而开发。
同时,生物防治在种子处理应用上的日益普及,正透过以微生物製剂取代新烟碱类等受监管的合成化学品,改变作物早期保护的方式。这种方法使有益微生物能够在种子萌发后立即定殖于根际,从而在关键的早期生长阶段提供针对土壤传播病原体的系统性防御,并提高作物对非生物胁迫的耐受性。这种向主要作物的转变,正在为小众特色水果和蔬菜以外的市场开闢巨大的潜力。 Evogene公司于2024年11月宣布了其Yaros生物接种剂的商业性扩张计划,该计划旨在将其种子处理生物接种剂推广到美国大豆市场,目标是新增8600万英亩(约3440万公顷)此前主要由传统材料主导的种植面积。
The Global Biocontrol Market is projected to expand from USD 4.21 Billion in 2025 to USD 6.78 Billion by 2031, registering a CAGR of 8.26%. This sector focuses on managing agricultural pests and plant diseases by utilizing natural organisms and substances, such as microbials, macrobials, and semiochemicals. Key factors propelling this growth include increasingly strict government mandates designed to limit synthetic chemical usage and the growing worldwide consumer preference for food free of chemical residues. Additionally, the adoption of these biological agents is being actively reinforced by the urgent need for robust resistance management strategies to address pests that have developed immunity to traditional pesticides.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.21 Billion |
| Market Size 2031 | USD 6.78 Billion |
| CAGR 2026-2031 | 8.26% |
| Fastest Growing Segment | Macrobials |
| Largest Market | North America |
Despite this upward trajectory, the industry encounters significant hurdles. Data from the International Biocontrol Manufacturers Association indicates that while the European biocontrol market reached a value of 1.6 billion Euros in 2024 with a growth rate near 10 percent, broader expansion is hindered by a complicated and disjointed regulatory landscape. Inconsistent and protracted approval procedures across various regions often postpone the commercial launch of products, limiting manufacturers' capacity to swiftly bring new innovations to market to satisfy agricultural demands.
Market Driver
Strategic capital allocation and portfolio diversification by leading agrochemical companies serve as primary engines for market growth. Confronted with regulatory restrictions on synthetics and market instability, industry giants are aggressively shifting focus toward biological product lines to ensure stable revenue sources. This strategic realignment is generating concrete operational benefits; for instance, Corteva Agriscience reported in its 'Fourth Quarter 2024 Results' in February 2025 that crop protection volumes rose by 16 percent year-over-year, a surge largely attributed to strong demand for biologicals and novel products in Latin America. Such corporate dedication facilitates the swift commercialization of sophisticated formulations, effectively connecting specialized research with mass-market accessibility.
The extensive implementation of Integrated Pest Management (IPM) strategies further supports this expansion as cultivators look for sustainable methods to manage resistance. Farmers are increasingly utilizing biological inputs alongside conventional treatments, a shift that is altering distribution strategies. According to the '2025 Biologicals Survey' by CropLife in March 2025, 86 percent of agricultural retailers surveyed intend to expand their range of biological products for the coming season. This surging demand is creating significant market value in major agricultural zones; as noted by Revista Cultivar in November 2025, sales of biological pesticides in Brazil reached R$ 4.35 billion for the 2024/25 crop cycle, marking an 18 percent rise over the previous year.
Market Challenge
A disjointed and intricate regulatory landscape remains a major hurdle to the Global Biocontrol Market's growth. In contrast to synthetic agrochemicals, biological products frequently lack specific registration pathways in many regions, compelling manufacturers to adhere to burdensome assessment protocols intended for chemical substances. This lack of alignment leads to excessive data demands and prohibitive compliance costs that fall heavily on small and medium-sized enterprises, which are often the sector's key innovators. Consequently, the financial strain and uncertainty associated with the approval process deter investment in new product development and postpone the release of sustainable pest control solutions.
The consequences of these regulatory inefficiencies are especially evident when comparing different regional markets. The International Biocontrol Manufacturers Association reported in 2024 that European farmers endure waiting periods of up to ten years for biocontrol product approval, whereas competitors in the United States or Brazil generally gain market access within two to three years. This substantial discrepancy limits the supply of effective biological options in areas with sluggish approval systems, thereby constraining the overall market potential and hindering the industry's ability to satisfy the pressing global need for residue-free agricultural inputs.
Market Trends
The rise of RNA-interference (RNAi) based biopesticide technologies marks a pivotal transition toward highly targeted, non-genetic pest management solutions that tackle the escalating problem of chemical resistance. Unlike conventional broad-spectrum inputs, these sprayable formulations employ double-stranded RNA to silence specific genes in target pests without modifying the crop's genome or damaging beneficial insects, thus bypassing the regulatory and public acceptance challenges linked to GMOs. Commercial momentum in this sector is gathering pace as manufacturers advance products from field trials to mass distribution; for example, GreenLight Biosciences announced in March 2025 that it secured $25 million in financing to expand commercial operations for Calantha, the first registered foliar RNA biopesticide developed to combat the Colorado potato beetle.
Simultaneously, the increasing use of biocontrols in seed treatment applications is transforming early-season crop protection by substituting restricted synthetic chemistries, such as neonicotinoids, with microbial inoculants. This approach ensures that beneficial organisms inhabit the rhizosphere immediately after germination, offering systemic protection against soil-borne pathogens and improving resilience to abiotic stress during the crucial establishment stage. This shift toward major row crops is opening up significant market possibilities beyond niche specialty fruits and vegetables; as reported by Evogene in November 2024 regarding the commercial expansion of Yalos, the extension of its bio-inoculant seed treatment into the United States soybean market targets an additional 86 million acres previously dominated by conventional inputs.
Report Scope
In this report, the Global Biocontrol Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Biocontrol Market.
Global Biocontrol Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: